A 2025 npj Metabolic Health study found retatrutide reduced pancreatic tumor size by up to 93% in obese mice while also impacting lung tumor formation and immune signaling pathways. Here is what the findings could mean for the future of peptide research and why compounds like retatrutide are drawing major scientific attention.
Explore the growing interest in kisspeptin research and how this peptide is shaping conversations around endocrine signaling, peptide science, and modern laboratory research. Learn why researchers are increasingly focused on compounds like kisspeptin and the future of peptide research.
Social media restrictions on peptide related content are limiting education, visibility, and growth across the research industry. This article explores how inconsistent rules and content suppression are holding back innovation and what businesses can do to adapt.
Peptide research is entering a new era of growth and innovation. Discover how increased attention, scientific curiosity, and improved sourcing standards are shaping the future of research peptides with Peptide911.
The FDA’s April 30, 2026 announcement marks a turning point in how compounded medications—especially those tied to peptides and GLP-1
Explore how peptides for longevity like FOXO4, MOTS-c, and Epitalon are being studied in modern research. Learn how telomeres and cellular aging play a role in long term health and performance.
Men’s Health just spotlighted the “Wolverine stack” and now everyone is talking about BPC 157. Is it real recovery science or just hype? Here’s the full breakdown.
Explore the growing demand for research peptides, how availability may shift, and what to look for in a reliable peptide supplier. This guide breaks down sourcing standards, market trends, and how peptide911 supports researchers with consistent, high-quality peptide access.
“Researchers are asking what is next for peptide availability and pricing. Here is what we are seeing and how Peptide911 is positioned moving forward.”